| 产品编号 | CFN60025 | |
| CAS编号 | 231277-92-2 | |
| 分子式 = 分子量 | C29H26ClFN4O4S = 581.06 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 拉帕替尼 | CFN60025 | 231277-92-2 | 1mg | QQ客服:215959384 |
| 拉帕替尼 | CFN60025 | 231277-92-2 | 5mg | QQ客服:215959384 |
| 拉帕替尼 | CFN60025 | 231277-92-2 | 10mg | QQ客服:215959384 |
| 拉帕替尼 | CFN60025 | 231277-92-2 | 20mg | QQ客服:215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively. Lapatinib induces ferroptosis and autophagic cell death. |
| Targets: | EGFR | ErbB2 |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.721 mL | 8.605 mL | 17.2099 mL | 34.4199 mL | 43.0248 mL |
| 5 mM | 0.3442 mL | 1.721 mL | 3.442 mL | 6.884 mL | 8.605 mL |
| 10 mM | 0.1721 mL | 0.8605 mL | 1.721 mL | 3.442 mL | 4.3025 mL |
| 50 mM | 0.0344 mL | 0.1721 mL | 0.3442 mL | 0.6884 mL | 0.8605 mL |
| 100 mM | 0.0172 mL | 0.086 mL | 0.1721 mL | 0.3442 mL | 0.4302 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 4’7-二甲氧基-5-羟基异黄酮; 7-O-Methylbiochanin A | CFN91010 | 34086-51-6 | C17H14O5 = 298.3 | 10mg | QQ客服:1413575084 |
| 蔓茎毒毛旋花子苷; Sarmentocymarin | CFN89202 | 98633-61-5 | C30H46O8 = 534.69 | 5mg | QQ客服:2056216494 |
| 恩杂鲁胺; Enzalutamide (MDV3100) | CFN60057 | 915087-33-1 | C21H16F4N4O2S = 464.44 | 5mg | QQ客服:2056216494 |
| 3-羟基黄酮; Flavonol | CFN70151 | 577-85-5 | C15H10O3 = 238.2 | 20mg | QQ客服:1457312923 |